Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · IEX Real-Time Price · USD
5.39
+0.29 (5.69%)
May 1, 2024, 4:00 PM EDT - Market closed

Lantern Pharma Market Cap

Lantern Pharma has a market cap or net worth of $57.99 million as of May 1, 2024. Its market cap has increased by 15.06% in one year.

Market Cap
57.99M
Enterprise Value
17.47M
1-Year Change
15.06%
Ranking
Category
Stock Price
$5.39

Market Cap Chart

Since June 11, 2020, Lantern Pharma's market cap has decreased from $90.20M to $57.99M, a decrease of -35.71%. That is a compound annual growth rate of -10.74%.

History

DateMarket Cap% Change
Apr 30, 202454.80M3.40%
Apr 29, 202453.00M-10.32%
Apr 26, 202459.10M0.85%
Apr 25, 202458.60M1.38%
Apr 24, 202457.80M-6.77%
Apr 23, 202462.00M0.98%
Apr 22, 202461.40M6.97%
Apr 19, 202457.40M-7.42%
Apr 18, 202462.00M-3.58%
Apr 17, 202464.30M-0.16%
Apr 16, 202464.40M0.47%
Apr 15, 202464.10M-6.56%
Apr 12, 202468.60M-4.19%
Apr 11, 202471.60M-13.84%
Apr 10, 202483.10M-0.36%
Apr 9, 202483.40M-0.36%
Apr 8, 202483.70M0.36%
Apr 5, 202483.40M7.47%
Apr 4, 202477.60M-16.38%
Apr 3, 202492.80M-5.60%
Apr 2, 202498.30M-3.72%
Apr 1, 2024102.10M8.04%
Mar 28, 202494.50M-10.09%
Mar 27, 2024105.10M-2.41%
Mar 26, 2024107.70M1.03%
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Hyperfine 60.85M
Mural Oncology 60.58M
Equillium 60.29M
Kronos Bio 60.10M
Theratechnologies 59.77M
Kezar Life Sciences 58.60M
SCYNEXIS 58.14M
Cidara Therapeutics 57.61M
Market Cap Rankings